# Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

> **NCT03665506** · — · COMPLETED · sponsor: **Servier** · enrollment: 315 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Trifluridin/Tipiracil

## Key facts

- **NCT ID:** NCT03665506
- **Lead sponsor:** Servier
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-25
- **Primary completion:** 2021-08-02
- **Final completion:** 2021-08-02
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665506, "Trifluridin/tipirACil in MeTastatIc Colorectal Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03665506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*